Literature DB >> 1164817

Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxylase.

P F Teychenne, D B Calne, P J Lewis, L J Findley.   

Abstract

Drug interactions between levodopa, tranylcypromine, and carbidopa have been studied in 4 patients with idiopathic parkinsonism. Pressor responses were induced by a combination of levodopa and tranylcypromine. These hypertensive reactions were inhibited by carbidopa, indicating that they are mediated at the periphery. Very small doses of levodopa induced an improvement in parkinsonism when patients were concomitantly taking carbidopa and tranylcypromine, but adverse reactions were prominent.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1164817     DOI: 10.1002/cpt1975183273

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

Review 1.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 2.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide.

Authors:  M Mayersohn; T W Guentert
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

4.  Lifestyle advice in general practice: rates recalled by patients.

Authors:  C Silagy; J Muir; A Coulter; M Thorogood; P Yudkin; L Roe
Journal:  BMJ       Date:  1992-10-10

5.  Tranylcypromine isomers and Parkinson's disease: new aspects of an old drug.

Authors:  G P Reynolds; P Riederer; M Sandler
Journal:  J R Soc Med       Date:  1981-09       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.